BioCentury
ARTICLE | Finance

Nimbus looks inward

Why Atlas sees value in Nimbus’ plan to keep some assets to itself

June 8, 2018 2:58 PM UTC

Nimbus plans to use a $65 million financing it raised on Tuesday to take programs deeper in development, refining its founding strategy of partnering its compounds early on.

Existing investor Atlas Venture led the round, which saw participation from all of Nimbus’ other existing investors: SR One, Lilly Ventures, Bill Gates, Pfizer Venture Investments, Lightstone Ventures and Schrödinger...